19 results
8-K
EX-99.1
VTRS
Viatris Inc
15 Dec 23
Departure of Directors or Certain Officers
5:00pm
, including planning and overseeing the successful execution of large Phase III clinical studies. Prior to his tenure at Celgene, Martin held multiple
PRE 14A
VTRS
Viatris Inc
24 Oct 23
Preliminary proxy
4:30pm
structure following the 2023 Annual Meeting. The Board also committed to selecting a new independent Chair of the Board whose tenure will begin following … the transition of Mr. Malik’s substantial operating responsibilities given his significant tenure with the Company and primary responsibility for operation
8-K
x3ihymelu2bc6n zzn2
20 Oct 23
Departure of Directors or Certain Officers
5:18pm
8-K
EX-99.1
vymw2kfkdozgr9yhcf6x
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
vmqjnwef cuo83jsax8
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.1
nmmqm7
29 Dec 22
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney
4:14pm
SC TO-T
EX-99
ipd08
1 Dec 22
Third party tender offer statement
6:06am
DEF 14A
9s8q880zu ctvi
29 Oct 21
Definitive proxy
4:35pm
8-K
EX-99.1
8ea8bh53f0w4reqjfygu
6 Aug 20
Regulation FD Disclosure
5:21pm
10-12G
EX-99.1
sgli157y
12 Jun 20
Registration of securities
5:04pm
- Prev
- 1
- Next